Large-scale production of pharmaceutical proteins in plant cell culture-the protalix experience

Plant Biotechnology Journal

Volumn 13, Issue 8, 2015, Pages 1199-1208

  Tekoah, Yoram ^a   Shulman, Avidor ^a   Kizhner, Tali ^a   Ruderfer, Ilya ^a   Fux, Liat ^a   Nataf, Yakir ^a   Bartfeld, Daniel ^a   Ariel, Tami ^a   Gingis Velitski, Svetlana ^a   Hanania, Uri ^a   Shaaltiel, Yoseph ^a  

^a Protalix Biotherapeutics   (Israel)

Author keywords

Enzyme replacement therapy; Molecular farming; Oral delivery; Plant cell culture; Protalix Biotherapeutics; glucocerebrosidase

Indexed keywords

RECOMBINANT PROTEIN;

BIOREACTOR; BIOSYNTHESIS; CELL CULTURE TECHNIQUE; DRUG INDUSTRY; GLYCOSYLATION; HUMAN; IMMUNOLOGY; METABOLISM; PLANT CELL; PROCEDURES;

BIOREACTORS; CELL CULTURE TECHNIQUES; DRUG INDUSTRY; GLYCOSYLATION; HUMANS; PLANT CELLS; RECOMBINANT PROTEINS;

EID: 84942193222     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12428     Document Type: Review

References (68)

1. Bardor, M., Faveeuw, C., Fitchette, A.C., Gilbert, D., Galas, L., Trottein, F., Faye, L. and Lerouge, P. (2003) Immunoreactivity in mammals of two typical plant glyco-epitopes, core α(1, 3)-fucose and core xylose. Glycobiology, 13, 427-434.
2. Benchabane, M., Rivard, D., Girard, C. and Michaud, D. (2009) Companion protease inhibitors to protect recombinant proteins in transgenic plant extracts. Methods Mol. Biol. 483, 265-273.
3. Bortesi, L. and Fischer, R. (2015) The CRISPR/Cas9 system for plant genome editing and beyond. Biotechnol. Adv. 33, 41-52.
4. Cai, C.Q., Doyon, Y., Ainley, W.M., Miller, J.C., Dekelver, R.C., Moehle, E.A., Rock, J.M., Lee, Y.L., Garrison, R., Schulenberg, L., Blue, R., Worden, A., Baker, L., Faraji, F., Zhang, L., Holmes, M.C., Rebar, E.J., Collingwood, T.N., Rubin-Wilson, B., Gregory, P.D., Urnov, F.D. and Petolino, J.F. (2009) Targeted transgene integration in plant cells using designed zinc finger nucleases. Plant Mol. Biol. 69, 699-709.
5. Clarke, J.T. (2007) Narrative review: Fabry disease. Ann. Intern. Med. 146, 425-433.
6. Cox, K.M., Sterling, J.D., Regan, J.T., Gasdaska, J.R., Frantz, K.K., Peele, C.G., Black, A., Passmore, D., Moldovan-Loomis, C., Srinivasan, M., Cuison, S., Cardarelli, P.M. and Dickey, L.F. (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol. 24, 1591-1597.
7. Cramer, C.L., Boothe, J.G. and Oishi, K.K. (2000) Transgenic plants for therapeutic proteins: linking upstream and downstream strategies. Curr. Top. Microbiol. Immunol. 240, 95-118.
8. Dingermann, T. (2008) Recombinant therapeutic proteins: production platforms and challenges. Biotechnol. J. 3, 90-97.
9. Doran, P.M. (1999) Design of mixing systems for plant cell suspensions in stirred reactors. Biotechnol. Prog. 15, 319-335.
10. Eamens, A., Wang, M.B., Smith, N.A. and Waterhouse, P.M. (2008) RNA silencing in plants: yesterday, today, and tomorrow. Plant Physiol. 147, 456-468.
11. Elbers, I.J., Stoopen, G.M., Bakker, H., Stevens, L.H., Bardor, M., Molthoff, J.W., Jordi, W.J., Bosch, D. and Lommen, A. (2001) Influence of growth conditions and developmental stage on N-glycan heterogeneity of transgenic immunoglobulin G and endogenous proteins in tobacco leaves. Plant Physiol. 126, 1314-1322.
12. European Medicines Agency (2006) ICH Topic Q 5 D Guideline, quality of biotechnological products: derivation and characterisation of cell substrates used for production of biotechnological/biological products, Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003280.pdf (Accessed: May 14, 2015).
13. European Medicines Agency (2013) Guideline on the quality of biological active substances produced by stable transgene expression in higher plants, Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003153.pdf (Accessed: August 29, 2013).
14. FDA (2001) Guidance for industry Q7A good manufacturing practice guidance for active pharmaceutical ingredients. Available at: http://www.fda.gov/downloads/Drugs/%e2%80%a6/Guidances/ucm073497.pdf (Accessed: May 14, 2015).
15. FDA (2009a) Guidance for industry Q10 pharmaceutical quality system. Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm073517.pdf (Accessed: March 16, 2015).
16. FDA (2009b) Guidance for industry Q8(R2) pharmaceutical development. Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm073507.pdf (Accessed: March 16, 2015).
17. Fischer, R., Schillberg, S., Buyel, J.F. and Twyman, R.M. (2013) Commercial aspects of pharmaceutical protein production in plants. Curr. Pharm. Des. 19, 5471-5477.
18. Fox, J.L. (2012) First plant-made biologic approved. Nat. Biotechnol. 30, 472.
19. Garman, S.C. and Garboczi, D.N. (2004) The molecular defect leading to Fabry disease: structure of human α-galactosidase. J. Mol. Biol. 337, 319-335.
20. Gelvin, S.B. (2003) Agrobacterium-mediated plant transformation: the biology behind the "gene-jockeying" tool. Microbiol. Mol. Biol. Rev. 67, 16-37.
21. Gomord, V. and Faye, L. (2004) Posttranslational modification of therapeutic proteins in plants. Curr. Opin. Plant Biol. 7, 171-181.
22. Grabowski, G.A., Golembo, M. and Shaaltiel, Y. (2014) Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Mol. Genet. Metab. 112, 1-8.
23. Hassan, S., van Dolleweerd, C.J., Ioakeimidis, F., Keshavarz-Moore, E. and Ma, J.K. (2008) Considerations for extraction of monoclonal antibodies targeted to different subcellular compartments in transgenic tobacco plants. Plant Biotechnol. J. 6, 733-748.
24. Hellwig, S., Drossard, J., Twyman, R.M. and Fischer, R. (2004) Plant cell cultures for the production of recombinant proteins. Nat. Biotechnol. 22, 1415-1422.
25. Jurjus, A., Khoury, N. and Reimund, J. (2004) Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods, 50, 81-92.
26. Karnoup, A.S., Turkelson, V. and Anderson, W.H.K. (2005) O-Linked glycosylation in maize-expressed human IgA1. Glycobiology, 15, 965-981.
27. Kieran, P.M., MacLoughlin, P.F. and Malone, D.M. (1997) Plant cell suspension cultures: some engineering considerations. J. Biotechnol. 59, 39-52.
28. Kim, T.G., Lee, H.J., Jang, Y.S., Shin, Y.J., Kwon, T.H. and Yang, M.S. (2008) Co-expression of proteinase inhibitor enhances recombinant human granulocyte-macrophage colony stimulating factor production in transgenic rice cell suspension culture. Protein Expr. Purif. 61, 117-121.
29. Kizhner, T., Azulay, Y., Hainrichson, M., Tekoah, Y., Arvatz, G., Shulman, A., Ruderfer, I., Aviezer, D. and Shaaltiel, Y. (2014) Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease. Mol. Genet. Metab. 114, 259-267.
30. Ko, K., Tekoah, Y., Rudd, P.M., Harvey, D.J., Dwek, R.A., Spitin, S., Hanlon, C.A., Rupprecht, C., Dietzschold, B., Golovkin, M. and Koprowski, H. (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl Acad. Sci. USA, 100, 8013-8018.
31. Landry, N., Ward, B.J., Trepanier, S., Montomoli, E., Dargis, M., Lapini, G. and Vézina, L.-P. (2010) Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One, 5, e15559.
32. Li, Z., Xing, A., Moon, B.P., McCardell, R.P., Mills, K. and Falco, S.C. (2009) Site-specific integration of transgenes in soybean via recombinase mediated DNA cassette exchange. Plant Physiol. 151, 1087-1095.
33. Louwerse, J.D., van Lier, M.C., van der Steen, D.M., de Vlaam, C.M., Hooykaas, P.J. and Vergunst, A.C. (2007) Stable recombinase-mediated cassette exchange in Arabidopsis using Agrobacterium tumefaciens. Plant Physiol. 145, 1282-1293.
34. Love, D.C. and Hanover, J.A. (2005) The hexosamine signaling pathway: deciphering the "O-GlcNAc Code". Sci. STKE. 2005, re13.
35. Nanto, K., Sato, K., Katayama, Y. and Ebinuma, H. (2009) Expression of a transgene exchanged by the recombinase-mediated cassette exchange (RMCE) method in plants. Plant Cell Rep. 28, 777-785.
36. Nuttall, J., Vine, N., Hadlington, J.L., Drake, P., Frigerio, L. and Ma, J.K. (2002) ER-resident chaperone interactions with recombinant antibodies in transgenic plants. Eur. J. Biochem. 269, 6042-6051.
37. Parekh, S., Srinivasan, V. and Horn, M. (2008) Bioprocessing using novel cell culture systems. Adv. Appl. Microbiol. 63, 105-143.
38. Plasson, C., Michel, R., Lienard, D., Saint-Jore-Dupas, C., Sourrouille, C., de March, G.G. and Gomord, V. (2009) Production of recombinant proteins in suspension-cultured plant cells. Methods Mol. Biol. 483, 145-161.
39. Porteus, M.H. (2009) Plant biotechnology: Zinc fingers on target. Nature, 459, 337-338.
40. Raffaele, S., Bayer, E., Lafarge, D., Cluzet, S., German Retana, S., Boubekeur, T., Leborgne-Castel, N., Carde, J.-P., Lherminier, J., Noirot, E., Satiat Jeunemâtre, B., Laroche-Traineau, J., Moreau, P., Ott, T., Maule, A.J., Reymond, F., Simon-Plas, F., Farmer, E.E., Bessoule, J.-J. and Mongranda, S. (2009) Remorin, a solanaceae protein resident in membrane rafts and plasmodesmata, impairs potato virus X movement. Plant Cell, 21, 1541-1555.
41. Raven, N., Rasche, S., Kuehn, C., Anderlei, T., Klöckner, W., Schuster, F., Henquet, M., Bosch, D., Büchs, J., Fischer, R. and Schillberg, S. (2015) Scaled-up manufacturing of recombinant antibodies produced by plant cells in a 200-L orbitally-shaken disposable bioreactor. Biotechnol. Bioeng. 112, 308-321.
42. Rosales-Mendoza, S. and Tello-Olea, M.A. (2015) Carrot cells: a pioneering platform for biopharmaceuticals production. Mol. Biotechnol. 57, 219-232.
43. Schahs, M., Strasser, R., Stadlmann, J., Kunert, R., Rademacher, T. and Steinkellner, H. (2007) Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol. J. 5, 657-663.
44. Schell, J. and Van Montagu, M. (1977) The Ti-plasmid of Agrobacterium tumefaciens, a natural vector for the introduction of nif genes in plants? Basic Life Sci. 9, 159-179.
45. Scholthof, H.B. (2005) Plant virus transport: motions of functional equivalence. Trends Plant Sci. 10, 376-382.
46. Scott, L.J. (2014) Etanercept: a review of its use in autoimmune inflammatory diseases. Drugs, 74, 1379-1410.
47. Shaaltiel, Y., Bartfeld, D., Hashmueli, S., Baum, G., Brill-Almon, E., Galili, G., Dym, O., Boldin-Adamsky, S.A., Silman, I., Sussman, J.L., Futerman, A.H. and Aviezer, D. (2007) Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher disease using a plant cell system. Plant Biotechnol. J. 5, 579-590.
48. Shaaltiel, Y., Hashmueli, S., Bartfeld, D., Baum, G., Ratz, T., Mizrachi, E. and Forster, Y. (2012) System and method for production of antibodies in plant cell culture. Patent no.: US 8119406 B2, Feb 21, 2012.
49. Shaaltiel, Y., Gingis-Velitski, S., Tzaban, S., Fiks, N., Tekoah, Y. and Aviezer, D. (2015) Plant based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher disease. Plant Biotechnol. J. doi:10.1111/pbi.12366.
50. Shukla, V.K., Doyon, Y., Miller, J.C., DeKelver, R.C., Moehle, E.A., Worden, S.E., Mitchell, J.C., Arnold, N.L., Gopalan, S., Meng, X., Choi, V.M., Rock, J.M., Wu, Y.Y., Katibah, G.E., Zhifang, G., McCaskill, D., Simpson, M.A., Blakeslee, B., Greenwalt, S.A., Butler, H.J., Hinkley, S.J., Zhang, L., Rebar, E.J., Gregory, P.D. and Urnov, F.D. (2009) Precise genome modification in the crop species Zea mays using zinc-finger nucleases. Nature, 459, 437-441.
51. Sijmons, P.C., Dekker, B.M., Schrammeijer, B., Verwoerd, T.C., van den Elzen, P.J. and Hoekema, A. (1990) Production of correctly processed human serum albumin in transgenic plants. Biotechnology (NY), 8, 217-221.
52. Sodoyer, R. (2004) Expression systems for the production of recombinant pharmaceuticals. BioDrugs, 18, 51-62.
53. Sourrouille, C., Marquet-Blouin, E., D'Aoust, M.A., Kiefer-Meyer, M.C., Seveno, M., Pagny-Salehabadi, S., Bardor, M., Durambur, G., Lerouge, P., Vezina, L. and Gomord, V. (2008) Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol. J. 6, 702-721.
54. Strasser, R., Altmann, F., Mach, L., Glossl, J. and Steinkellner, H. (2004) Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1, 2-linked xylose and core alpha1, 3-linked fucose. FEBS Lett. 561, 132-136.
55. Strasser, R., Stadlmann, J., Schahs, M., Stiegler, G., Quendler, H., Mach, L., Glossl, J., Weterings, K., Pabst, M. and Steinkellner, H. (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J. 6, 392-402.
56. Tekoah, Y. (2006) Post translational modifications to plants - glycosylation. In Encyclopedia of Genomics, Proteomics and Bioinformatics, 3:3.5 (Dunn, M., Jorde, L., Little, P. and Subramaniam, S., eds), Chichester: John Wiley & Sons Ltd., doi: 10.1002/047001153X.g305321.
57. Tekoah, Y., Ko, K., Koprowski, H., Harvey, D.J., Wormald, M., Dwek, R.A. and Rudd, P.M. (2004) Controlled glycosylation of therapeutic antibodies in plants. Arch. Biochem. Biophys. 426, 266-278.
58. Tekoah, Y., Tzaban, S., Kizhner, T., Hainrichson, M., Gantman, A., Golembo, M., Aviezer, D. and Shaaltiel, Y. (2013) Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems. Biosci. Rep. 33, 771-781.
59. Terrier, B., Courtois, D., Henault, N., Cuvier, A., Bastin, M., Aknin, A., Dubreuil, J. and Petiard, V. (2007) Two new disposable bioreactors for plant cell culture: the wave and undertow bioreactor and the slug bubble bioreactor. Biotechnol. Bioeng. 96, 914-923.
60. Tovkach, A., Zeevi, V. and Tzfira, T. (2009) A toolbox and procedural notes for characterizing novel zinc finger nucleases for genome editing in plant cells. Plant J. 57, 747-757.
61. Townsend, J.A., Wright, D.A., Winfrey, R.J., Fu, F., Maeder, M.L., Joung, J.K. and Voytas, D.F. (2009) High-frequency modification of plant genes using engineered zinc-finger nucleases. Nature, 459, 442-445.
62. Tsoi, B.M. and Doran, P.M. (2002) Effect of medium properties and additives on antibody stability and accumulation in suspended plant cell cultures. Biotechnol. Appl. Biochem. 35, 171-180.
63. Tzfira, T. and Citovsky, V. (2006) Agrobacterium-mediated genetic transformation of plants: biology and biotechnology. Curr. Opin. Biotechnol. 17, 147-154.
64. Ward, B.J., Landry, N., Trépanier, S., Mercier, G., Dargis, M., Couture, M., D'Aoust, M.-A. and Vézina, L.-P. (2014) Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines. Vaccine, 32, 6098-6106.
65. Wright, D.A., Townsend, J.A., Winfrey, R.J. Jr, Irwin, P.A., Rajagopal, J., Lonosky, P.M., Hall, B.D., Jondle, M.D. and Voytas, D.F. (2005) High-frequency homologous recombination in plants mediated by zinc-finger nucleases. Plant J. 44, 693-705.
66. Yamauchi, T., Johzuka-Hisatomi, Y., Fukada-Tanaka, S., Terada, R., Nakamura, I. and Iida, S. (2009) Homologous recombination-mediated knock-in targeting of the MET1a gene for a maintenance DNA methyltransferase reproducibly reveals dosage-dependent spatiotemporal gene expression in rice. Plant J. 60, 386-396.
67. Zhang, Y., Zhang, F., Li, X., Baller, J.A., Qi, Y., Starker, C.G., Bogdanove, A.J. and Voytas, D.F. (2013) Transcription activator-like effector nucleases enable efficient plant genome engineering. Plant Physiol. 161, 20-27.
68. Zhong, J.J. (2001) Biochemical engineering of the production of plant-specific secondary metabolites by cell suspension cultures. Adv. Biochem. Eng. Biotechnol. 72, 1-26.